Bioatla Inc (BCAB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.89M
Last updated: Nov 13, 2026 at 4:00 PM ET
Bioatla Inc (BCAB) Competitors
The companies most similar to Bioatla are Calidi Biotherapeutics (CLDI), PharmaCyte Biotech (PMCB) and Ernexa Therapeutics (ERNA). By market cap, Bioatla ranks 9th of the 13 companies on this page; Alaunos Therapeutics (TCRT) is the largest at $6.86M.
Peer Comparison
BCAB's revenue growth of 31.6% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Bioatla (BCAB) | $2.89M | N/A | N/A | 0.0% | N/A | 31.6% | 0.00% |
| Calidi Biotherapeutics Inc. (CLDI) | $2.29M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| Alaunos Therapeutics Inc (TCRT) | $6.86M | N/A | N/A | 0.0% | N/A | -25.0% | 0.00% |
| Azitra Inc (AZTR) | $3.69M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | $3.93M | N/A | 4.0x | 0.0% | N/A | 0.0% | 0.00% |
| Purple Biotech (PPBT) | $2.65M | N/A | N/A | 0.0% | -156.2% | 0.0% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $4.02M | N/A | N/A | 0.0% | -247.2% | 0.0% | 0.00% |
| Imunon Inc (IMNN) | $4.08M | N/A | N/A | 0.0% | -131.5% | 0.0% | 0.00% |
| Revelation Biosciences Inc (REVB) | $2.43M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Traws Pharma Inc (TRAW) | $3.86M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Creative Medical Technology Holdings Inc (CELZ) | $4.01M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $3.82M | N/A | 4.0x | 0.0% | -156.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Bioatla, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Calidi Biotherapeutics Inc. (CLDI) | Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. | CLDI competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Ernexa Therapeutics Inc. (ERNA) | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
| Alaunos Therapeutics Inc (TCRT) | Alaunos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on discovering, acquiring... | TCRT competitors |
| Azitra Inc (AZTR) | Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live... | AZTR competitors |
| XTL Biopharmaceuticals Ltd ADR (XTLB) | XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment... | |
| Purple Biotech (PPBT) | Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United... | PPBT competitors |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California. | LIMN competitors |
| Imunon Inc (IMNN) | Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious... | IMNN competitors |
| Revelation Biosciences Inc (REVB) | Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics... | REVB competitors |
| Traws Pharma Inc (TRAW) | Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. | TRAW competitors |
| Creative Medical Technology Holdings Inc (CELZ) | Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics... | CELZ competitors |
Frequently Asked Questions About BCAB
Who are Bioatla's main competitors?
The companies most similar to Bioatla include Calidi Biotherapeutics (CLDI), PharmaCyte Biotech (PMCB), Ernexa Therapeutics (ERNA), Alaunos Therapeutics (TCRT) and Azitra (AZTR), listed from the closest match.
Who is Bioatla's biggest competitor?
Alaunos Therapeutics (TCRT) is the largest of the similar companies at $6.86M; Calidi Biotherapeutics (CLDI) is the closest match by business profile, size, sector and industry.
How does BCAB stock compare with its competitors?
BCAB's net margin is 0.0% against a peer median of 0.0%.
Which of Bioatla's competitors pays a higher dividend?
Bioatla pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Bioatla bigger than its competitors?
No. Bioatla is 9th by market cap among the 13 companies on this page; the largest is Alaunos Therapeutics (TCRT) at $6.86M.
BCAB pages: Overview, Earnings, Financials, Competitors